Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AS012 in non-segmental vitiligo
NCT04487860Phase 2Completed
- Sponsor
- Aché Laboratórios Farmacêuticos
- Start
- Jan 2021
- Primary completion
- May 2022
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of AS012 in Vitiligo, sponsored by Aché Laboratórios Farmacêuticos. Started Jan 2021; status: completed.
02
Drugs
AS012
03
Conditions
Vitiligo
Beyond the preview
Go deeper on NCT04487860.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04487860.